Methylmalonic acid induces inflammatory response and redox homeostasis disruption in C6 astroglial cells: potential glioprotective roles of melatonin and resveratrol
- PMID: 35927507
- DOI: 10.1007/s00726-022-03191-z
Methylmalonic acid induces inflammatory response and redox homeostasis disruption in C6 astroglial cells: potential glioprotective roles of melatonin and resveratrol
Abstract
Methylmalonic acidemia is a neurometabolic disorder biochemically characterized by the accumulation of methylmalonic acid (MMA) in different tissues, including the central nervous system (CNS). In this sense, it has been shown that high levels of this organic acid have a key role in the progressive neurological deterioration in patients. Astroglial cells actively participate in a wide range of CNS functions, such as antioxidant defenses and inflammatory response. Considering the role of these cells to maintain brain homeostasis, in the present study, we investigated the effects of MMA on glial parameters, focusing on redox homeostasis and inflammatory process, as well as putative mediators of these events in C6 astroglial cells. MMA decreased cell viability, glutathione levels, and antioxidant enzyme activities, increased inflammatory response, and changed the expression of nuclear factor erythroid 2-related factor 2 (Nrf2), nuclear factor kappa B (NFκB), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), and adenosine receptors, suggesting that these transcriptional factors and proteins may underlie the glial responses induced by MMA. Moreover, we also demonstrated the protective roles of melatonin and resveratrol against MMA-induced inflammation and decrease in glutathione levels. In summary, our findings support the hypothesis that astroglial changes are associated with pathogenesis of methylmalonic acidemia. In addition, we showed that these cells might be potential targets for preventive/therapeutic strategies by using molecules, such as melatonin and resveratrol, which mediated glioprotection in this inborn error of metabolism.
Keywords: Antioxidant defenses; Astroglial cells; Inflammation; Melatonin; Methylmalonic academia; Methylmalonic acid; Resveratrol.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Similar articles
-
Glioprotective Effects of Resveratrol Against BMAA-Induced Astroglial Dysfunctions.Neurotox Res. 2022 Apr;40(2):530-541. doi: 10.1007/s12640-022-00492-9. Epub 2022 Mar 23. Neurotox Res. 2022. PMID: 35320508
-
Chronic administration of methylmalonate on young rats alters neuroinflammatory markers and spatial memory.Immunobiology. 2013 Sep;218(9):1175-83. doi: 10.1016/j.imbio.2013.04.008. Epub 2013 Apr 19. Immunobiology. 2013. PMID: 23726524
-
Methylmalonic Acid Impairs Cell Respiration and Glutamate Uptake in C6 Rat Glioma Cells: Implications for Methylmalonic Acidemia.Cell Mol Neurobiol. 2023 Apr;43(3):1163-1180. doi: 10.1007/s10571-022-01236-1. Epub 2022 Jun 8. Cell Mol Neurobiol. 2023. PMID: 35674974 Free PMC article.
-
Potential Glioprotective Strategies Against Diabetes-Induced Brain Toxicity.Neurotox Res. 2021 Oct;39(5):1651-1664. doi: 10.1007/s12640-021-00393-3. Epub 2021 Jul 14. Neurotox Res. 2021. PMID: 34258694 Review.
-
Novel insights of dietary polyphenols and obesity.J Nutr Biochem. 2014 Jan;25(1):1-18. doi: 10.1016/j.jnutbio.2013.09.001. J Nutr Biochem. 2014. PMID: 24314860 Free PMC article. Review.
Cited by
-
Glioprotective Effects of Resveratrol Against Glutamate-Induced Cellular Dysfunction: The Role of Heme Oxygenase 1 Pathway.Neurotox Res. 2025 Jan 27;43(1):7. doi: 10.1007/s12640-025-00730-w. Neurotox Res. 2025. PMID: 39869271
-
Association between methylmalonic acid and prevalence of depression in US adults: evidence from NHANES 2011-2014.Eur J Psychotraumatol. 2025 Dec;16(1):2450109. doi: 10.1080/20008066.2025.2450109. Epub 2025 Feb 13. Eur J Psychotraumatol. 2025. PMID: 39943880 Free PMC article.
-
Neurodegenerative biomarkers and inflammation in patients with propionic and methylmalonic acidemias: effect of L-carnitine treatment.Metab Brain Dis. 2024 Nov 16;40(1):6. doi: 10.1007/s11011-024-01475-9. Metab Brain Dis. 2024. PMID: 39549096
-
Serum methylmalonic acid concentrations at breast cancer diagnosis significantly correlate with clinical frailty.Geroscience. 2024 Apr;46(2):1489-1498. doi: 10.1007/s11357-023-00908-0. Epub 2023 Aug 26. Geroscience. 2024. PMID: 37632634 Free PMC article.
-
Melatonin Synergises the Chemotherapeutic Effect of Temozolomide in Glioblastoma by Suppressing NF-κB/COX-2 Signalling Pathways.J Cell Mol Med. 2025 Aug;29(15):e70778. doi: 10.1111/jcmm.70778. J Cell Mol Med. 2025. PMID: 40804775 Free PMC article.
References
-
- Ahmed SM, Luo L, Namani A, Wang XJ, Tang X (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys Acta 1863:585–597. https://doi.org/10.1016/j.bbadis.2016.11.005 - DOI
-
- An D et al (2017) Systemic messenger RNA therapy as a treatment for methylmalonic acidemia. Cell Rep 21:3548–3558. https://doi.org/10.1016/j.celrep.2017.11.081 - DOI - PubMed - PMC
-
- Arus BA, Souza DG, Bellaver B, Souza DO, Goncalves CA, Quincozes-Santos A, Bobermin LD (2017) Resveratrol modulates GSH system in C6 astroglial cells through heme oxygenase 1 pathway. Mol Cell Biochem 428:67–77. https://doi.org/10.1007/s11010-016-2917-5 - DOI - PubMed
-
- Baird L, Dinkova-Kostova AT (2011) The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85:241–272. https://doi.org/10.1007/s00204-011-0674-5 - DOI - PubMed
-
- Batinic-Haberle I, Tovmasyan A, Roberts ER, Vujaskovic Z, Leong KW, Spasojevic I (2014) SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal 20:2372–2415. https://doi.org/10.1089/ars.2012.5147 - DOI - PubMed - PMC
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials